234 related articles for article (PubMed ID: 26526451)
1. Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
Rogal SS; Yan P; Rimland D; Lo Re V; Al-Rowais H; Fried L; Butt AA;
Dig Dis Sci; 2016 Mar; 61(3):930-6. PubMed ID: 26526451
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
[TBL] [Abstract][Full Text] [Related]
4. HCV infection and the incidence of CKD.
Butt AA; Wang X; Fried LF
Am J Kidney Dis; 2011 Mar; 57(3):396-402. PubMed ID: 21185632
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
Lucas GM; Jing Y; Sulkowski M; Abraham AG; Estrella MM; Atta MG; Fine DM; Klein MB; Silverberg MJ; Gill MJ; Moore RD; Gebo KA; Sterling TR; Butt AA;
J Infect Dis; 2013 Oct; 208(8):1240-9. PubMed ID: 23904290
[TBL] [Abstract][Full Text] [Related]
6. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
[TBL] [Abstract][Full Text] [Related]
8. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans.
Molnar MZ; Alhourani HM; Wall BM; Lu JL; Streja E; Kalantar-Zadeh K; Kovesdy CP
Hepatology; 2015 May; 61(5):1495-502. PubMed ID: 25529816
[TBL] [Abstract][Full Text] [Related]
9. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease.
Chen YC; Lin HY; Li CY; Lee MS; Su YC
Kidney Int; 2014 May; 85(5):1200-7. PubMed ID: 24257691
[TBL] [Abstract][Full Text] [Related]
10. Fast GFR decline and progression to CKD among primary care patients with preserved GFR.
Koraishy FM; Hooks-Anderson D; Salas J; Rauchman M; Scherrer JF
Int Urol Nephrol; 2018 Mar; 50(3):501-508. PubMed ID: 29404927
[TBL] [Abstract][Full Text] [Related]
11. HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES.
Butt AA; Ren Y; Puenpatom A; Arduino JM; Kumar R; Abou-Samra AB
Liver Int; 2018 Aug; 38(8):1411-1417. PubMed ID: 29271562
[TBL] [Abstract][Full Text] [Related]
12. Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans.
Gosmanova EO; Molnar MZ; Alrifai A; Lu JL; Streja E; Cushman WC; Kalantar-Zadeh K; Kovesdy CP
Am J Nephrol; 2015; 42(2):151-7. PubMed ID: 26398170
[TBL] [Abstract][Full Text] [Related]
13. Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection.
Tartof SY; Hsu JW; Wei R; Rubenstein KB; Hu H; Arduino JM; Horberg M; Derose SF; Qian L; Rodriguez CV
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1471-1478. PubMed ID: 30242027
[TBL] [Abstract][Full Text] [Related]
14. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
Kidney Int; 2017 Sep; 92(3):703-709. PubMed ID: 28532708
[TBL] [Abstract][Full Text] [Related]
15. Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression.
Novak M; Mucsi I; Rhee CM; Streja E; Lu JL; Kalantar-Zadeh K; Molnar MZ; Kovesdy CP
Diabetes Care; 2016 Nov; 39(11):1940-1947. PubMed ID: 27311494
[TBL] [Abstract][Full Text] [Related]
16. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
[TBL] [Abstract][Full Text] [Related]
17. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.
Lazo M; Nwankwo C; Daya NR; Thomas DL; Mehta SH; Juraschek S; Willis K; Selvin E
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1957-1964.e7. PubMed ID: 28579183
[TBL] [Abstract][Full Text] [Related]
18. Exercise capacity and risk of chronic kidney disease in US veterans: a cohort study.
Kokkinos P; Faselis C; Myers J; Sui X; Zhang J; Tsimploulis A; Chawla L; Palant C
Mayo Clin Proc; 2015 Apr; 90(4):461-8. PubMed ID: 25792243
[TBL] [Abstract][Full Text] [Related]
19. Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.
Chen JY; Ren Y; Yan P; Belina ME; Chung RT; Butt AA
J Viral Hepat; 2018 Jul; 25(7):825-833. PubMed ID: 29478294
[TBL] [Abstract][Full Text] [Related]
20. Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea.
Lee SS; Jeong SH; Jang ES; Kim YS; Lee YJ; Jung EU; Kim IH; Bae SH; Lee HC; Kee MK; Kang C
J Gastroenterol Hepatol; 2015 Aug; 30(8):1281-7. PubMed ID: 25778783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]